| Diana Velazquez Gonzalez, | |
|
924 Calle Munoz Rivera, Penuelas, PR 00624-1410 | |
| (787) 908-2394 | |
| Not Available |
| Full Name | Diana Velazquez Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 924 Calle Munoz Rivera, Penuelas, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992105241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 70132 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Velazquez Gonzalez, 924 Calle Munoz Rivera, Penuelas, PR 00624-1410 Ph: (787) 908-2394 | Diana Velazquez Gonzalez, 924 Calle Munoz Rivera, Penuelas, PR 00624-1410 Ph: (787) 908-2394 |
News Archive
One in four elderly Americans require someone else to make decisions about their medical care at the end of their lives, according to a new study in the New England Journal of Medicine.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced it has received two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.
Transfusion of red blood cells (RBCs) stored anaerobically – in the absence of oxygen – is a promising technique to improve resuscitation from hemorrhagic shock, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.
People may count sheep when they cannot sleep, but when they do finally drift off their brains generate the same type of brain wave as their ovine counterparts, according to new research published in eNeuro. Monitoring how a sheep's sleep changes during the progression of a brain disease may one day translate to sleep-based diagnosis in humans.
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania.
› Verified 3 days ago